Kingbuild Pharmaceuticals Private Limited
About Kingbuild Pharmaceuticals Private Limited
Data last updated:
Kingbuild Pharmaceuticals Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 24 November 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51909GJ2017PTC099928. Its GSTIN is 24AAGCK8542C1ZP (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rakesh Kumar Jena (Managing Director) and Bikash Kumar Jena.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Shop No – 11 Ground Floor Green Orien Jehangirabad Canal Road, Surat, Gujarat, India – 395005.
As per the financials filed for FY 2021, the company reported a revenue of ₹30,800, a decline of 52% compared to the previous year. For the same year it recorded a net loss of ₹64,435 (net margin -209.2%) and EBITDA of -₹64,435 (EBITDA margin -209.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kingbuild Pharmaceuticals Private Limited's registered office is in Surat, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressShop No – 11 Ground Floor Green Orien Jehangirabad Canal Road, Surat, Gujarat, India – 395005
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Kingbuild Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kingbuild Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kingbuild Pharmaceuticals Private Limited, buy the company report.
Financials of Kingbuild Pharmaceuticals Private Limited
FY 2021 filings availableKingbuild Pharmaceuticals Private Limited reported revenue of ₹30,800 (down 52% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue fell 52% in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹64,435 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹64,435 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -209.2% | |||
| Net Profit Margin | -209.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Kingbuild Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kingbuild Pharmaceuticals Private Limited
Kingbuild Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bikash Kumar Jena Also directs: Kingbuild Marketing Private Limited | Director | 24 Nov 2017 | 8 Years 11 Months | Current |
| Rakesh Kumar Jena | Managing Director | 24 Nov 2017 | 8 Years 11 Months | Current |
Peer comparison
Kingbuild Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Deepvin Pharmaceuticals Private Limited | ₹31,729 (FY 2024) | -82.0% | Lucknow, Uttar Pradesh, India | |||
| Neopower Pharmaceuticals Private Limited | ₹31,100 (FY 2024) | -93.0% | Hazaribagh, Jharkhand, India | |||
| Kingbuild Pharmaceuticals Private Limitedthis company | ₹30,800 (FY 2021) | -₹64,435 | -209.2% | -52.0% | Surat, Gujarat, India | |
| Westal Pharmaceuticals Private Limited | ₹30,143 (FY 2021) | -80.0% | Agra, Uttar Pradesh, India | |||
| Ssbell Pharmaceuticals Private Limited | ₹30,020 (FY 2025) | -40.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Kingbuild Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kingbuild Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kingbuild Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kingbuild Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCK8542C1ZP | Gujarat | Active | 05 Jul 2018 |
To see the full GST registrations and return filing status of Kingbuild Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kingbuild Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Bikash Kumar Jena was appointed as Director on 24 Nov 2017.
Frequently asked questions
Kingbuild Pharmaceuticals is an active private limited company based in Surat, Gujarat, India. The company works in specialty, within the trading industry. It was incorporated on 24 November 2017 (9+ years old) and is registered under CIN U51909GJ2017PTC099928.
Kingbuild Pharmaceuticals has 2 current directors:
- Rakesh Kumar Jena - Managing Director
- Bikash Kumar Jena - Director
The latest financial statements of Kingbuild Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Kingbuild Pharmaceuticals is 24AAGCK8542C1ZP, registered in Gujarat.
The CIN (Corporate Identification Number) of Kingbuild Pharmaceuticals is U51909GJ2017PTC099928. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kingbuild Pharmaceuticals was incorporated on 24 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Kingbuild Pharmaceuticals by revenue are Deepvin Pharmaceuticals Private Limited, Neopower Pharmaceuticals Private Limited, Westal Pharmaceuticals Private Limited, Ssbell Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Bikash Kumar Jena was appointed as Director on 24 Nov 2017. Rakesh Kumar Jena was appointed as Managing Director on 24 Nov 2017.
The registered office of Kingbuild Pharmaceuticals is at Shop No – 11 Ground Floor Green Orien Jehangirabad Canal Road, Surat, Gujarat, India – 395005.
Kingbuild Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Kingbuild Pharmaceuticals is compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
